131I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndrome

This publication has 15 references indexed in Scilit:

• Carcinoid Tumors
  New England Journal of Medicine, 1999
• Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours
  European Journal of Nuclear Medicine and Molecular Imaging, 1998
• 17. Response to 131I-MIBG therapy in patients with metastases from neuroendocrine tumours
  Nuclear Medicine Communications, 1998
• Yttrium-90-labelled somatostatin-analogue for cancer treatment
  The Lancet, 1998
• Gastrointestinal carcinoids—aspects of diagnosis and classification
  APMIS, 1996
• Hepatic resection for metastatic neuroendocrine carcinomas
  The American Journal of Surgery, 1995
• Historical Background and Natural History of Carcinoids
  Digestion, 1994
• Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria
  Investigational New Drugs, 1992
• The effect of a somatostatin analogue on the release of hormones from human midgut carcinoid tumour cells
  British Journal of Cancer, 1991
• Apudomas metastatic to the liver: treatment by hepatic artery embolization.
  Radiology, 1983